# OnCo record weizmann (institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/institutions/weizmann/>
  a schema:MedicalOrganization ;
  onco:kind "institution" ;
  schema:identifier "weizmann" ;
  schema:name "Weizmann Institute of Science"@en ;
  schema:alternateName "Weizmann Institute"@en, "Moross Integrated Cancer Center"@en ;
  schema:description "Israel's basic research institute, whose HER receptor, p53, single-cell immunology and microbiome discoveries have shaped cancer biology."@en ;
  schema:url <https://onco.cc/institutions/weizmann/>, <https://www.weizmann.ac.il> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:citation <https://www.weizmann.ac.il>, <https://www.weizmann.ac.il/MICC/> ;
  schema:addressCountry "IL" ;
  schema:addressLocality "Rehovot" ;
  schema:latitude "31.907"^^xsd:decimal ;
  schema:longitude "34.811"^^xsd:decimal ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/aml/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/single-cell-spatial/>, <https://onco.cc/technologies/crispr-screens/>, <https://onco.cc/technologies/proteomics/> ;
  onco:targets <https://onco.cc/targets/her2/>, <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/tp53/> ;
  onco:institutions <https://onco.cc/institutions/sheba/>, <https://onco.cc/institutions/rambam/> ;
  onco:terms <https://onco.cc/terms/neoantigen/> ;
  onco:people <https://onco.cc/people/alon-chen/>, <https://onco.cc/people/zelig-eshhar/>, <https://onco.cc/people/yardena-samuels/>, <https://onco.cc/people/yosef-yarden/>, <https://onco.cc/people/moshe-oren/> .